| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | STAB2 PCDHGC5 SPTA1 PCDHB7 CBL ZZEF1 ITGB1 LRP1B SVEP1 EYS CELSR1 FAT2 FBN1 FBN2 HMCN2 NRXN1 PCDH15 LRP1 MACF1 CLEC3B PLS3 NOTCH1 | 1.38e-06 | 749 | 182 | 22 | GO:0005509 |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 3.54e-05 | 21 | 182 | 4 | GO:0030228 | |
| GeneOntologyMolecularFunction | frizzled binding | 3.85e-05 | 42 | 182 | 5 | GO:0005109 | |
| GeneOntologyMolecularFunction | chemoattractant activity involved in axon guidance | 2.46e-04 | 3 | 182 | 2 | GO:1902379 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 3.13e-04 | 15 | 182 | 3 | GO:0010484 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 3.82e-04 | 16 | 182 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | endopeptidase activity | KLK11 USP34 ADAM30 PRSS33 ADAM11 MST1 CFD ADAMTS6 ADAMTS15 C2 MST1L USP1 | 6.04e-04 | 430 | 182 | 12 | GO:0004175 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 7.48e-04 | 118 | 182 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | integrin binding involved in cell-matrix adhesion | 8.11e-04 | 5 | 182 | 2 | GO:0098640 | |
| GeneOntologyBiologicalProcess | complement activation, classical pathway | 2.18e-06 | 44 | 180 | 6 | GO:0006958 | |
| GeneOntologyBiologicalProcess | complement activation | 2.59e-06 | 70 | 180 | 7 | GO:0006956 | |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 6.45e-06 | 5 | 180 | 3 | GO:0061642 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway | USP34 WNT5A WNT7B WNT8B JADE1 WNT5B CELSR1 SALL1 RUVBL1 TLR2 LRP1 LRP5 MACF1 DKK4 NOTCH1 LRRFIP2 | 1.26e-05 | 516 | 180 | 16 | GO:0016055 |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | SEMA3F SEMA7A KIF26B WNT5A WNT7B ITGB1 MST1 SALL1 LRP1 MACF1 MST1L NOTCH1 | 1.32e-05 | 299 | 180 | 12 | GO:0060560 |
| GeneOntologyBiologicalProcess | humoral immune response mediated by circulating immunoglobulin | 1.67e-05 | 62 | 180 | 6 | GO:0002455 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | KIF26B WNT5A WNT7B SOCS3 APAF1 RREB1 ITGB1 WNT5B MST1 CELSR1 SALL1 PCDH15 LRP5 MST1L CSMD1 NOTCH1 JHY | 3.16e-05 | 619 | 180 | 17 | GO:0002009 |
| GeneOntologyBiologicalProcess | positive regulation of apoptotic cell clearance | 3.54e-05 | 8 | 180 | 3 | GO:2000427 | |
| GeneOntologyBiologicalProcess | mammary gland duct morphogenesis | 4.41e-05 | 45 | 180 | 5 | GO:0060603 | |
| GeneOntologyBiologicalProcess | positive regulation of mammary gland epithelial cell proliferation | 5.28e-05 | 9 | 180 | 3 | GO:0033601 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic cell clearance | 7.50e-05 | 10 | 180 | 3 | GO:2000425 | |
| GeneOntologyBiologicalProcess | mammary gland epithelium development | 9.40e-05 | 84 | 180 | 6 | GO:0061180 | |
| GeneOntologyBiologicalProcess | actin filament network formation | 1.02e-04 | 11 | 180 | 3 | GO:0051639 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | KIF26B WNT5A WNT7B SOCS3 APAF1 RREB1 ITGB1 WNT5B MST1 CELSR1 SALL1 PCDH15 LRP5 MACF1 MST1L CSMD1 NOTCH1 JHY | 1.04e-04 | 750 | 180 | 18 | GO:0048729 |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via JAK-STAT | 1.15e-04 | 125 | 180 | 7 | GO:0046425 | |
| GeneOntologyBiologicalProcess | endocytosis | LDLRAP1 STAB2 RHOJ WNT5A CARMIL1 KIAA0319L IRF8 CBL ITGB1 LRP1B GHR CACNG8 TLR2 LRP1 LRP5 C2 C4A C4B VAV3 | 1.18e-04 | 827 | 180 | 19 | GO:0006897 |
| GeneOntologyBiologicalProcess | tube morphogenesis | PDE3B STAB2 RHOJ KIF26B WNT5A TMIGD2 WNT7B APAF1 ITGB1 ITGB8 MST1 CELSR1 PTPRB SALL1 NRXN1 ARID2 LRP1 LRP5 VAV3 MST1L CSMD1 NIPBL NOTCH1 | 1.28e-04 | 1125 | 180 | 23 | GO:0035239 |
| GeneOntologyBiologicalProcess | regulation of cell motility | SEMA3F SIN3B RELN SYNPO2 ZNF609 PRR5L SEMA7A RHOJ WNT5A CARMIL1 RREB1 ITGB1 WNT5B MST1 FBN2 ARID2 SYNE2 TLR2 LRP1 MACF1 MST1L STK24 NIPBL NOTCH1 DUOXA2 | 1.31e-04 | 1280 | 180 | 25 | GO:2000145 |
| GeneOntologyBiologicalProcess | regulation of cell migration | SEMA3F SIN3B RELN SYNPO2 ZNF609 PRR5L SEMA7A RHOJ WNT5A CARMIL1 RREB1 ITGB1 WNT5B MST1 FBN2 ARID2 SYNE2 TLR2 LRP1 MACF1 MST1L STK24 NIPBL NOTCH1 | 1.45e-04 | 1211 | 180 | 24 | GO:0030334 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | ZBTB17 WNT5A WNT7B WNT8B SOCS3 APAF1 WNT5B CELSR1 FBN2 ARFRP1 SALL1 PCDH15 LRP5 MACF1 ANKRD24 NIPBL NOTCH1 | 1.77e-04 | 713 | 180 | 17 | GO:0048598 |
| GeneOntologyBiologicalProcess | positive regulation of macrophage cytokine production | 1.88e-04 | 33 | 180 | 4 | GO:0060907 | |
| GeneOntologyBiologicalProcess | immune effector process | SEMA7A WNT5A SOCS3 IRF8 CBL SVEP1 JAK3 CFD CD19 CARD9 HPRT1 TLR2 LRP1 C2 C4A C4B VAV3 C8A C9 | 1.92e-04 | 859 | 180 | 19 | GO:0002252 |
| GeneOntologyBiologicalProcess | mammary gland epithelial cell proliferation | 2.12e-04 | 34 | 180 | 4 | GO:0033598 | |
| GeneOntologyBiologicalProcess | positive regulation of cell motility | SEMA3F RELN SYNPO2 ZNF609 SEMA7A RHOJ WNT5A CARMIL1 RREB1 ITGB1 WNT5B SYNE2 TLR2 LRP1 NIPBL NOTCH1 DUOXA2 | 2.15e-04 | 725 | 180 | 17 | GO:2000147 |
| GeneOntologyBiologicalProcess | ureteric bud invasion | 2.26e-04 | 3 | 180 | 2 | GO:0072092 | |
| GeneOntologyBiologicalProcess | cardiac right atrium morphogenesis | 2.26e-04 | 3 | 180 | 2 | GO:0003213 | |
| GeneOntologyBiologicalProcess | regulation of locomotion | SEMA3F SIN3B RELN SYNPO2 ZNF609 PRR5L SEMA7A RHOJ WNT5A CARMIL1 RREB1 ITGB1 WNT5B MST1 FBN2 ARID2 SYNE2 TLR2 LRP1 MACF1 MST1L STK24 NIPBL NOTCH1 DUOXA2 | 2.28e-04 | 1327 | 180 | 25 | GO:0040012 |
| GeneOntologyBiologicalProcess | mammary gland morphogenesis | 2.59e-04 | 65 | 180 | 5 | GO:0060443 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via STAT | 2.65e-04 | 143 | 180 | 7 | GO:1904892 | |
| GeneOntologyBiologicalProcess | positive regulation of locomotion | SEMA3F RELN SYNPO2 ZNF609 SEMA7A RHOJ WNT5A CARMIL1 RREB1 ITGB1 WNT5B SYNE2 TLR2 LRP1 NIPBL NOTCH1 DUOXA2 | 2.81e-04 | 742 | 180 | 17 | GO:0040017 |
| GeneOntologyBiologicalProcess | central nervous system development | SEMA3F KIF21B RELN MCPH1 SEMA7A WNT5A WNT7B CYP26A1 APAF1 ITGB1 CELSR1 SALL1 NRXN1 HPRT1 SYNE2 TLR2 LRP1 NAV2 LRP5 NIPBL MYO16 NOTCH1 JHY | 3.13e-04 | 1197 | 180 | 23 | GO:0007417 |
| GeneOntologyBiologicalProcess | positive regulation of cell migration | SEMA3F RELN SYNPO2 ZNF609 SEMA7A RHOJ WNT5A CARMIL1 RREB1 ITGB1 WNT5B SYNE2 TLR2 LRP1 NIPBL NOTCH1 | 3.80e-04 | 691 | 180 | 16 | GO:0030335 |
| GeneOntologyBiologicalProcess | regulation of Wnt signaling pathway | USP34 WNT5A JADE1 WNT5B SALL1 RUVBL1 TLR2 LRP1 MACF1 DKK4 NOTCH1 | 4.04e-04 | 368 | 180 | 11 | GO:0030111 |
| GeneOntologyBiologicalProcess | metanephric renal vesicle formation | 4.49e-04 | 4 | 180 | 2 | GO:0072093 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 4.49e-04 | 4 | 180 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | ZNF609 PCDHGC5 KIF26B WNT5A TMIGD2 SPTA1 WNT7B PCDHB7 ITGB1 ITGB8 SVEP1 JAK3 SLC7A1 CELSR1 FAT2 HMCN2 NRXN1 ARID2 PCDH15 LRP5 NOTCH1 | 4.79e-04 | 1077 | 180 | 21 | GO:0098609 |
| GeneOntologyBiologicalProcess | positive regulation of Wnt signaling pathway | 4.84e-04 | 158 | 180 | 7 | GO:0030177 | |
| GeneOntologyCellularComponent | external encapsulating structure | RELN SEMA7A WNT5A PAPLN COL22A1 ADAM11 ADAMTSL3 ITGB1 PKHD1L1 SVEP1 WNT5B MST1 EYS FBN1 FBN2 HMCN2 ADAMTS6 SBSPON ADAMTS15 NAV2 CLEC3B | 3.41e-07 | 658 | 183 | 21 | GO:0030312 |
| GeneOntologyCellularComponent | extracellular matrix | RELN SEMA7A WNT5A PAPLN COL22A1 ADAM11 ADAMTSL3 ITGB1 SVEP1 WNT5B MST1 EYS FBN1 FBN2 HMCN2 ADAMTS6 SBSPON ADAMTS15 NAV2 CLEC3B | 1.34e-06 | 656 | 183 | 20 | GO:0031012 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | RELN SEMA7A WNT5A PAPLN COL22A1 ADAM11 ITGB1 WNT5B MST1 EYS FBN1 FBN2 HMCN2 SBSPON ADAMTS15 NAV2 CLEC3B | 4.47e-06 | 530 | 183 | 17 | GO:0062023 |
| GeneOntologyCellularComponent | other organism part | 5.33e-05 | 9 | 183 | 3 | GO:0044217 | |
| GeneOntologyCellularComponent | stereocilium | 3.48e-04 | 69 | 183 | 5 | GO:0032420 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 5.76e-04 | 212 | 183 | 8 | GO:0030666 | |
| GeneOntologyCellularComponent | stereocilium bundle | 6.50e-04 | 79 | 183 | 5 | GO:0032421 | |
| MousePheno | increased neutrophil cell number | SYNPO2 SPTA1 SOCS3 IRF8 TNFRSF11A PKHD1L1 JAK3 FBN1 AARS2 NRXN1 HPRT1 NAV2 C4A C4B DUOXA2 | 9.81e-06 | 368 | 150 | 15 | MP:0000219 |
| Domain | EGF_1 | RELN STAB2 ADAM30 ADAM11 ITGB1 LRP1B ITGB8 SVEP1 TMEFF1 EYS CELSR1 FAT2 FBN1 FBN2 HMCN2 NRXN1 LRP1 LRP5 C8A C9 NOTCH1 | 6.57e-14 | 255 | 181 | 21 | PS00022 |
| Domain | EGF-like_CS | RELN STAB2 ADAM30 ADAM11 ITGB1 LRP1B ITGB8 SVEP1 TMEFF1 EYS CELSR1 FAT2 FBN1 FBN2 HMCN2 NRXN1 LRP1 LRP5 C8A C9 NOTCH1 | 1.04e-13 | 261 | 181 | 21 | IPR013032 |
| Domain | EGF_2 | RELN STAB2 ADAM30 ADAM11 LRP1B ITGB8 SVEP1 TMEFF1 EYS CELSR1 FAT2 FBN1 FBN2 HMCN2 NRXN1 LRP1 LRP5 C8A C9 NOTCH1 | 1.37e-12 | 265 | 181 | 20 | PS01186 |
| Domain | EGF_3 | RELN STAB2 ADAM30 ADAM11 LRP1B SVEP1 TMEFF1 EYS CELSR1 FAT2 FBN1 FBN2 HMCN2 NRXN1 LRP1 LRP5 C8A C9 NOTCH1 | 1.52e-12 | 235 | 181 | 19 | PS50026 |
| Domain | EGF-like_dom | RELN STAB2 ADAM30 ADAM11 LRP1B SVEP1 TMEFF1 EYS CELSR1 FAT2 FBN1 FBN2 HMCN2 NRXN1 LRP1 LRP5 C8A C9 NOTCH1 | 4.23e-12 | 249 | 181 | 19 | IPR000742 |
| Domain | EGF | RELN STAB2 ADAM11 LRP1B ITGB8 SVEP1 GPR179 TMEFF1 EYS CELSR1 FAT2 FBN1 FBN2 NRXN1 LRP1 LRP5 NOTCH1 | 1.39e-10 | 235 | 181 | 17 | SM00181 |
| Domain | EGF-like_Ca-bd_dom | STAB2 LRP1B SVEP1 EYS CELSR1 FAT2 FBN1 FBN2 HMCN2 LRP1 LRP5 NOTCH1 | 2.95e-09 | 124 | 181 | 12 | IPR001881 |
| Domain | Growth_fac_rcpt_ | STAB2 LRP1B SVEP1 GPR179 EYS CELSR1 FBN1 FBN2 HMCN2 LRP1 C8A C9 NOTCH1 | 4.02e-09 | 156 | 181 | 13 | IPR009030 |
| Domain | EGF_CA | STAB2 LRP1B SVEP1 EYS CELSR1 FAT2 FBN1 FBN2 HMCN2 LRP1 NOTCH1 | 2.88e-08 | 122 | 181 | 11 | SM00179 |
| Domain | ASX_HYDROXYL | 4.64e-08 | 100 | 181 | 10 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 8.12e-08 | 106 | 181 | 10 | IPR000152 | |
| Domain | EGF_extracell | 1.11e-07 | 60 | 181 | 8 | IPR013111 | |
| Domain | EGF_2 | 1.11e-07 | 60 | 181 | 8 | PF07974 | |
| Domain | TSP_1 | 1.64e-07 | 63 | 181 | 8 | PF00090 | |
| Domain | TSP1 | 2.10e-07 | 65 | 181 | 8 | SM00209 | |
| Domain | TSP1_rpt | 2.10e-07 | 65 | 181 | 8 | IPR000884 | |
| Domain | TSP1 | 2.10e-07 | 65 | 181 | 8 | PS50092 | |
| Domain | EGF | 4.16e-07 | 126 | 181 | 10 | PF00008 | |
| Domain | EGF_CA | 5.06e-07 | 99 | 181 | 9 | PS01187 | |
| Domain | EGF_Ca-bd_CS | 4.62e-06 | 97 | 181 | 8 | IPR018097 | |
| Domain | EGF_CA | 2.02e-05 | 86 | 181 | 7 | PF07645 | |
| Domain | Wnt | 2.95e-05 | 19 | 181 | 4 | IPR005817 | |
| Domain | WNT1 | 2.95e-05 | 19 | 181 | 4 | PS00246 | |
| Domain | Wnt_CS | 2.95e-05 | 19 | 181 | 4 | IPR018161 | |
| Domain | wnt | 2.95e-05 | 19 | 181 | 4 | PF00110 | |
| Domain | WNT1 | 2.95e-05 | 19 | 181 | 4 | SM00097 | |
| Domain | LDLR_class-A_CS | 4.04e-05 | 40 | 181 | 5 | IPR023415 | |
| Domain | Ldl_recept_a | 7.22e-05 | 45 | 181 | 5 | PF00057 | |
| Domain | Peptidase_M12B_ADAM-TS | 7.79e-05 | 24 | 181 | 4 | IPR013273 | |
| Domain | - | 8.03e-05 | 46 | 181 | 5 | 4.10.400.10 | |
| Domain | DUF5050 | 9.34e-05 | 2 | 181 | 2 | IPR032485 | |
| Domain | DUF5050 | 9.34e-05 | 2 | 181 | 2 | PF16472 | |
| Domain | LDLRA_1 | 9.88e-05 | 48 | 181 | 5 | PS01209 | |
| Domain | cEGF | 1.08e-04 | 26 | 181 | 4 | PF12662 | |
| Domain | cEGF | 1.08e-04 | 26 | 181 | 4 | IPR026823 | |
| Domain | LDrepeatLR_classA_rpt | 1.09e-04 | 49 | 181 | 5 | IPR002172 | |
| Domain | LDLa | 1.09e-04 | 49 | 181 | 5 | SM00192 | |
| Domain | LDLRA_2 | 1.09e-04 | 49 | 181 | 5 | PS50068 | |
| Domain | VWFA | 1.45e-04 | 82 | 181 | 6 | PS50234 | |
| Domain | hEGF | 1.46e-04 | 28 | 181 | 4 | PF12661 | |
| Domain | VWA | 1.66e-04 | 84 | 181 | 6 | SM00327 | |
| Domain | Laminin_G | 2.45e-04 | 58 | 181 | 5 | IPR001791 | |
| Domain | CARMIL_C | 2.78e-04 | 3 | 181 | 2 | IPR031943 | |
| Domain | CARMIL_C | 2.78e-04 | 3 | 181 | 2 | PF16000 | |
| Domain | FBN | 2.78e-04 | 3 | 181 | 2 | IPR011398 | |
| Domain | PLAC | 3.01e-04 | 14 | 181 | 3 | PF08686 | |
| Domain | Ldl_recept_b | 3.01e-04 | 14 | 181 | 3 | PF00058 | |
| Domain | LDLRB | 3.01e-04 | 14 | 181 | 3 | PS51120 | |
| Domain | LY | 3.74e-04 | 15 | 181 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 3.74e-04 | 15 | 181 | 3 | IPR000033 | |
| Domain | VWF_A | 4.05e-04 | 99 | 181 | 6 | IPR002035 | |
| Domain | CH | 4.17e-04 | 65 | 181 | 5 | SM00033 | |
| Domain | LAM_G_DOMAIN | 4.87e-04 | 38 | 181 | 4 | PS50025 | |
| Domain | Pep_M12B_propep | 5.38e-04 | 39 | 181 | 4 | PF01562 | |
| Domain | Peptidase_M12B_N | 5.38e-04 | 39 | 181 | 4 | IPR002870 | |
| Domain | CH | 5.88e-04 | 70 | 181 | 5 | PF00307 | |
| Domain | DISINTEGRIN_1 | 5.94e-04 | 40 | 181 | 4 | PS00427 | |
| Domain | Reprolysin | 5.94e-04 | 40 | 181 | 4 | PF01421 | |
| Domain | Laminin_G_2 | 5.94e-04 | 40 | 181 | 4 | PF02210 | |
| Domain | ADAM_MEPRO | 5.94e-04 | 40 | 181 | 4 | PS50215 | |
| Domain | DISINTEGRIN_2 | 5.94e-04 | 40 | 181 | 4 | PS50214 | |
| Domain | Peptidase_M12B | 5.94e-04 | 40 | 181 | 4 | IPR001590 | |
| Domain | - | 6.28e-04 | 71 | 181 | 5 | 1.10.418.10 | |
| Domain | Disintegrin_dom | 6.53e-04 | 41 | 181 | 4 | IPR001762 | |
| Domain | CH | 7.13e-04 | 73 | 181 | 5 | PS50021 | |
| Domain | - | 7.59e-04 | 74 | 181 | 5 | 3.40.50.410 | |
| Domain | PLAC | 7.74e-04 | 19 | 181 | 3 | PS50900 | |
| Domain | PLAC | 7.74e-04 | 19 | 181 | 3 | IPR010909 | |
| Domain | Kinesin-like_fam | 7.84e-04 | 43 | 181 | 4 | IPR027640 | |
| Domain | CH-domain | 8.07e-04 | 75 | 181 | 5 | IPR001715 | |
| Domain | Peptidase_S1A | 8.18e-04 | 113 | 181 | 6 | IPR001314 | |
| Domain | - | 8.56e-04 | 44 | 181 | 4 | 3.40.850.10 | |
| Domain | Kinesin | 8.56e-04 | 44 | 181 | 4 | PF00225 | |
| Domain | KISc | 8.56e-04 | 44 | 181 | 4 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 8.56e-04 | 44 | 181 | 4 | PS00411 | |
| Domain | Kinesin_motor_dom | 8.56e-04 | 44 | 181 | 4 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 8.56e-04 | 44 | 181 | 4 | PS50067 | |
| Domain | PSI | 8.56e-04 | 44 | 181 | 4 | IPR016201 | |
| Domain | LamG | 8.56e-04 | 44 | 181 | 4 | SM00282 | |
| Domain | TRYPSIN_DOM | 8.96e-04 | 115 | 181 | 6 | PS50240 | |
| Domain | Anaphylatoxin_comp_syst | 9.16e-04 | 5 | 181 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 9.16e-04 | 5 | 181 | 2 | IPR001840 | |
| Domain | PAN_AP | 9.16e-04 | 5 | 181 | 2 | SM00473 | |
| Domain | Tryp_SPc | 9.80e-04 | 117 | 181 | 6 | SM00020 | |
| Domain | PSI | 1.01e-03 | 46 | 181 | 4 | SM00423 | |
| Domain | Trypsin_dom | 1.17e-03 | 121 | 181 | 6 | IPR001254 | |
| Domain | Trypsin | 1.17e-03 | 121 | 181 | 6 | PF00089 | |
| Domain | Peptidase_S1_PA | 1.27e-03 | 123 | 181 | 6 | IPR009003 | |
| Domain | MACPF_CS | 1.37e-03 | 6 | 181 | 2 | IPR020863 | |
| Domain | Spectrin | 1.37e-03 | 23 | 181 | 3 | PF00435 | |
| Domain | ACTININ_2 | 1.37e-03 | 23 | 181 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.37e-03 | 23 | 181 | 3 | PS00019 | |
| Domain | ADAM_spacer1 | 1.37e-03 | 23 | 181 | 3 | IPR010294 | |
| Domain | Actinin_actin-bd_CS | 1.37e-03 | 23 | 181 | 3 | IPR001589 | |
| Domain | ADAM_spacer1 | 1.37e-03 | 23 | 181 | 3 | PF05986 | |
| Domain | ANATO | 1.90e-03 | 7 | 181 | 2 | SM00104 | |
| Domain | Pan_app | 1.90e-03 | 7 | 181 | 2 | IPR003609 | |
| Domain | TB | 1.90e-03 | 7 | 181 | 2 | PF00683 | |
| Domain | ANAPHYLATOXIN_2 | 1.90e-03 | 7 | 181 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 1.90e-03 | 7 | 181 | 2 | PS01177 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 2.85e-08 | 20 | 139 | 6 | M917 | |
| Pathway | WP_COMPLEMENT_ACTIVATION | 5.40e-08 | 22 | 139 | 6 | M39502 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 1.05e-07 | 13 | 139 | 5 | M4732 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 2.41e-07 | 15 | 139 | 5 | M7146 | |
| Pathway | WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY | 4.88e-07 | 17 | 139 | 5 | MM15944 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 4.88e-07 | 17 | 139 | 5 | MM1369 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 2.83e-06 | 11 | 139 | 4 | MM1430 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 4.21e-06 | 12 | 139 | 4 | MM1368 | |
| Pathway | WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY | 9.77e-06 | 106 | 139 | 8 | M42535 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 1.87e-05 | 84 | 139 | 7 | MM14653 | |
| Pathway | KEGG_MEDICUS_VARIANT_FZD7_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 2.93e-05 | 37 | 139 | 5 | M47411 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_ACYLATION | 3.13e-05 | 19 | 139 | 4 | M47836 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 3.19e-05 | 7 | 139 | 3 | MM14685 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 3.35e-05 | 38 | 139 | 5 | MM14874 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 3.81e-05 | 39 | 139 | 5 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 3.81e-05 | 39 | 139 | 5 | MM15165 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 4.47e-05 | 96 | 139 | 7 | M39581 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 5.07e-05 | 8 | 139 | 3 | M47872 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 5.07e-05 | 8 | 139 | 3 | M27031 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 5.46e-05 | 68 | 139 | 6 | M27303 | |
| Pathway | KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 5.94e-05 | 69 | 139 | 6 | M16894 | |
| Pathway | BIOCARTA_ALTERNATIVE_PATHWAY | 7.55e-05 | 9 | 139 | 3 | M22072 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY | 8.59e-05 | 46 | 139 | 5 | M47409 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 9.54e-05 | 47 | 139 | 5 | M646 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 9.75e-05 | 25 | 139 | 4 | MM14940 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 1.14e-04 | 26 | 139 | 4 | M27239 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 1.41e-04 | 115 | 139 | 7 | M19752 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 1.46e-04 | 11 | 139 | 3 | M47874 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_INHIBITOR | 1.54e-04 | 28 | 139 | 4 | M47835 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PTCH1_TO_HEDGEHOG_SIGNALING_PATHWAY | 1.78e-04 | 29 | 139 | 4 | M47372 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_SMO_TO_HEDGEHOG_SIGNALING_PATHWAY | 1.78e-04 | 29 | 139 | 4 | M47377 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.63e-04 | 32 | 139 | 4 | MM14854 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS | 3.91e-04 | 15 | 139 | 3 | M27273 | |
| Pathway | WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER | 4.13e-04 | 98 | 139 | 6 | M39731 | |
| Pathway | PID_IL4_2PATHWAY | 4.15e-04 | 64 | 139 | 5 | M28 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 4.17e-04 | 36 | 139 | 4 | M39699 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 4.64e-04 | 37 | 139 | 4 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 5.70e-04 | 39 | 139 | 4 | MM14601 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 7.27e-04 | 109 | 139 | 6 | MM15164 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 7.39e-04 | 151 | 139 | 7 | M19428 | |
| Pathway | WP_OXIDATIVE_DAMAGE_RESPONSE | 7.58e-04 | 42 | 139 | 4 | MM15945 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY | 7.63e-04 | 110 | 139 | 6 | MM15977 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 8.00e-04 | 111 | 139 | 6 | M27416 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 9.05e-04 | 44 | 139 | 4 | M26969 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 9.05e-04 | 44 | 139 | 4 | MM15878 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 9.70e-04 | 77 | 139 | 5 | MM14670 | |
| Pathway | KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 9.86e-04 | 45 | 139 | 4 | M47412 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 1.10e-03 | 118 | 139 | 6 | M39852 | |
| Pathway | REACTOME_SIGNALING_BY_MST1 | 1.41e-03 | 6 | 139 | 2 | MM15492 | |
| Pathway | REACTOME_SIGNALING_BY_LRP5_MUTANTS | 1.41e-03 | 6 | 139 | 2 | M27432 | |
| Pathway | BIOCARTA_TFF_PATHWAY | 1.63e-03 | 24 | 139 | 3 | M15926 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | SIN3B PDE3B MCPH1 BAZ2B KIF26B KIF21A SLC26A9 MAGI3 SRPRA ICE1 ARHGAP11A ZZEF1 TRIP12 MST1 GTF3C1 MCM3AP ADAMTS15 MTCL1 FUBP3 LRRFIP2 | 3.30e-09 | 736 | 186 | 20 | 29676528 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA3F USP34 SEMA7A WNT7B KIAA0319L SOCS3 EML2 PAPLN ICE1 JADE1 MED13L ZZEF1 REXO1 JAK3 SLC7A1 CELSR1 ZNF827 MCM3AP NAV2 LRP5 CEP131 NOTCH1 SMG6 | 3.03e-08 | 1105 | 186 | 23 | 35748872 |
| Pubmed | 3.72e-08 | 130 | 186 | 9 | 12421765 | ||
| Pubmed | Spatial and temporal expression of Wnt and Dickkopf genes during murine lens development. | 9.77e-08 | 9 | 186 | 4 | 15053977 | |
| Pubmed | 1.29e-07 | 23 | 186 | 5 | 27362799 | ||
| Pubmed | 1.51e-07 | 3 | 186 | 3 | 3902621 | ||
| Pubmed | Paths reunited: Initiation of the classical and lectin pathways of complement activation. | 1.51e-07 | 3 | 186 | 3 | 19783065 | |
| Pubmed | 4.16e-07 | 225 | 186 | 10 | 12168954 | ||
| Pubmed | 5.30e-07 | 30 | 186 | 5 | 15880404 | ||
| Pubmed | 6.00e-07 | 4 | 186 | 3 | 6088393 | ||
| Pubmed | 6.00e-07 | 4 | 186 | 3 | 25467802 | ||
| Pubmed | 6.00e-07 | 4 | 186 | 3 | 6190740 | ||
| Pubmed | The human complement system: assembly of the classical pathway C3 convertase. | 6.00e-07 | 4 | 186 | 3 | 6906228 | |
| Pubmed | 6.00e-07 | 4 | 186 | 3 | 19302245 | ||
| Pubmed | 1.03e-06 | 15 | 186 | 4 | 11429295 | ||
| Pubmed | 1.03e-06 | 15 | 186 | 4 | 15044261 | ||
| Pubmed | USP34 SIN3B ZNF609 MCPH1 ICE1 TSPYL1 MED13L HEXIM1 KANSL2 GTF3C1 ZNF827 PHF3 KIFC1 | 1.14e-06 | 453 | 186 | 13 | 29656893 | |
| Pubmed | 1.18e-06 | 35 | 186 | 5 | 19185060 | ||
| Pubmed | 1.37e-06 | 16 | 186 | 4 | 9889131 | ||
| Pubmed | 1.37e-06 | 16 | 186 | 4 | 10585256 | ||
| Pubmed | Protective T cell-independent antiviral antibody responses are dependent on complement. | 1.49e-06 | 5 | 186 | 3 | 10523614 | |
| Pubmed | 1.49e-06 | 5 | 186 | 3 | 22689574 | ||
| Pubmed | Formation of high affinity C5 convertase of the classical pathway of complement. | 1.49e-06 | 5 | 186 | 3 | 12878586 | |
| Pubmed | 1.49e-06 | 5 | 186 | 3 | 20038603 | ||
| Pubmed | 1.57e-06 | 37 | 186 | 5 | 15342465 | ||
| Pubmed | LDLRAP1 USP34 RELN ZBTB38 KIF21A KIAA0319L NASP MAGI3 MED13L TRIP12 LRP1B ITGB8 FAN1 TMEFF1 KANSL2 FBN1 LRP1 MACF1 ANKRD24 NIPBL COG4 ZMYM4 | 1.66e-06 | 1285 | 186 | 22 | 35914814 | |
| Pubmed | Wnt family proteins are secreted and associated with the cell surface. | 1.79e-06 | 17 | 186 | 4 | 8167409 | |
| Pubmed | Tissue-specific requirements of beta-catenin in external genitalia development. | 1.80e-06 | 38 | 186 | 5 | 18635608 | |
| Pubmed | 1.80e-06 | 38 | 186 | 5 | 23190887 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | SEMA3F USP34 GALNT10 WNT5A KIAA0319L SRPRA ZZEF1 ITGB1 LRP1B ITGB8 CELSR1 FBN1 FBN2 GTF3C1 RUVBL1 PPM1L LRP1 LRP5 C4A PLS3 NOTCH1 | 2.09e-06 | 1201 | 186 | 21 | 35696571 |
| Pubmed | Coronary Artery Formation Is Driven by Localized Expression of R-spondin3. | 2.88e-06 | 19 | 186 | 4 | 28834739 | |
| Pubmed | 2.88e-06 | 19 | 186 | 4 | 11520664 | ||
| Pubmed | USP34 SIN3B ZNF609 NUP88 ICE1 RREB1 RLF SALL1 GTF3C1 LRP1 CEP131 ZMYM4 | 2.95e-06 | 418 | 186 | 12 | 34709266 | |
| Pubmed | 2.97e-06 | 6 | 186 | 3 | 19710450 | ||
| Pubmed | Biochemical analysis of murine Wnt proteins reveals both shared and distinct properties. | 2.97e-06 | 6 | 186 | 3 | 7556445 | |
| Pubmed | 2.97e-06 | 6 | 186 | 3 | 162484 | ||
| Pubmed | 2.97e-06 | 6 | 186 | 3 | 1373817 | ||
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 4.21e-06 | 171 | 186 | 8 | 20201926 | |
| Pubmed | The WNT7b promoter is regulated by TTF-1, GATA6, and Foxa2 in lung epithelium. | 4.41e-06 | 21 | 186 | 4 | 11914369 | |
| Pubmed | Epithelial Wnt10a Is Essential for Tooth Root Furcation Morphogenesis. | 4.41e-06 | 21 | 186 | 4 | 31914354 | |
| Pubmed | 4.41e-06 | 21 | 186 | 4 | 19806668 | ||
| Pubmed | 5.19e-06 | 7 | 186 | 3 | 20139276 | ||
| Pubmed | 5.19e-06 | 7 | 186 | 3 | 8058323 | ||
| Pubmed | 5.19e-06 | 7 | 186 | 3 | 16651386 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ESPN GALNT10 PDE3B ZNF609 MCPH1 CARMIL1 WNT7B MAGI3 ITGB1 RLF SLC7A1 LRPPRC PTPRB GTF3C1 ZNF827 LRP1 LRP5 MACF1 ANKRD24 CSMD1 KAT6B ZMYM4 SMG6 | 5.24e-06 | 1489 | 186 | 23 | 28611215 |
| Pubmed | 5.30e-06 | 47 | 186 | 5 | 18351675 | ||
| Pubmed | Stromal R-spondin orchestrates gastric epithelial stem cells and gland homeostasis. | 5.30e-06 | 47 | 186 | 5 | 28813421 | |
| Pubmed | 5.30e-06 | 47 | 186 | 5 | 33141892 | ||
| Pubmed | Motor neurons with axial muscle projections specified by Wnt4/5 signaling. | 5.37e-06 | 22 | 186 | 4 | 19285468 | |
| Pubmed | 5.37e-06 | 22 | 186 | 4 | 12815618 | ||
| Pubmed | 5.37e-06 | 22 | 186 | 4 | 18991257 | ||
| Pubmed | Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes. | 6.21e-06 | 84 | 186 | 6 | 15203218 | |
| Pubmed | Wnt antagonist SFRP3 inhibits the differentiation of mouse hepatic progenitor cells. | 6.53e-06 | 49 | 186 | 5 | 19562671 | |
| Pubmed | 8.26e-06 | 8 | 186 | 3 | 20093360 | ||
| Pubmed | Expression of multiple novel Wnt-1/int-1-related genes during fetal and adult mouse development. | 8.26e-06 | 8 | 186 | 3 | 2279700 | |
| Pubmed | 8.26e-06 | 8 | 186 | 3 | 20870940 | ||
| Pubmed | Molecular genetics of the human MHC complement gene cluster. | 8.26e-06 | 8 | 186 | 3 | 10072631 | |
| Pubmed | A role for Wnt/beta-catenin signaling in lens epithelial differentiation. | 9.18e-06 | 25 | 186 | 4 | 12812787 | |
| Pubmed | KIF21B LDLRAP1 SIN3B ZNF609 LAMTOR5 NASP JADE1 MED13L ITGB1 HEXIM1 RLF MST1 SLC7A1 EAF1 SALL1 ARID2 MCM3AP METTL16 USP1 NIPBL ZMYM4 | 9.66e-06 | 1327 | 186 | 21 | 32694731 | |
| Pubmed | 1.11e-05 | 257 | 186 | 9 | 16335952 | ||
| Pubmed | 1.23e-05 | 9 | 186 | 3 | 12702652 | ||
| Pubmed | A new nomenclature for int-1 and related genes: the Wnt gene family. | 1.23e-05 | 9 | 186 | 3 | 1846319 | |
| Pubmed | Surviving mousepox infection requires the complement system. | 1.23e-05 | 9 | 186 | 3 | 19112490 | |
| Pubmed | 1.23e-05 | 9 | 186 | 3 | 11543617 | ||
| Pubmed | 1.26e-05 | 27 | 186 | 4 | 17804636 | ||
| Pubmed | 1.47e-05 | 28 | 186 | 4 | 20940229 | ||
| Pubmed | Ectodermal Wnt signaling regulates abdominal myogenesis during ventral body wall development. | 1.47e-05 | 28 | 186 | 4 | 24394376 | |
| Pubmed | SIN3B BAZ2B MAGI3 TRAPPC8 WDFY4 REXO1 FAN1 FAT2 AARS2 ARID2 MACF1 ANKRD24 | 1.55e-05 | 493 | 186 | 12 | 15368895 | |
| Pubmed | Mesenchymal Hox6 function is required for mouse pancreatic endocrine cell differentiation. | 1.64e-05 | 59 | 186 | 5 | 26450967 | |
| Pubmed | Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury. | 1.69e-05 | 29 | 186 | 4 | 22956684 | |
| Pubmed | 1.69e-05 | 29 | 186 | 4 | 18364260 | ||
| Pubmed | The evolutionarily conserved porcupine gene family is involved in the processing of the Wnt family. | 1.76e-05 | 10 | 186 | 3 | 10866835 | |
| Pubmed | Mouse Wnt genes exhibit discrete domains of expression in the early embryonic CNS and limb buds. | 1.76e-05 | 10 | 186 | 3 | 8275860 | |
| Pubmed | 1.76e-05 | 10 | 186 | 3 | 30429287 | ||
| Pubmed | 1.76e-05 | 10 | 186 | 3 | 21943708 | ||
| Pubmed | Expression patterns of Wnt genes during development of an anterior part of the chicken eye. | 1.76e-05 | 10 | 186 | 3 | 16258938 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.79e-05 | 101 | 186 | 6 | 23382219 | |
| Pubmed | A genome-wide association study of behavioral disinhibition. | 1.95e-05 | 30 | 186 | 4 | 23942779 | |
| Pubmed | 1.95e-05 | 30 | 186 | 4 | 19282366 | ||
| Pubmed | Atlas of Wnt and R-spondin gene expression in the developing male mouse lower urogenital tract. | 1.95e-05 | 30 | 186 | 4 | 21936019 | |
| Pubmed | Overactive Wnt5a signaling disrupts hair follicle polarity during mouse skin development. | 1.95e-05 | 30 | 186 | 4 | 36305473 | |
| Pubmed | 2.23e-05 | 31 | 186 | 4 | 37838801 | ||
| Pubmed | 2.41e-05 | 11 | 186 | 3 | 24639464 | ||
| Pubmed | Organizations and gene duplications of the human and mouse MHC complement gene clusters. | 2.41e-05 | 11 | 186 | 3 | 10686478 | |
| Pubmed | Genome-wide association study of lung function decline in adults with and without asthma. | 2.53e-05 | 32 | 186 | 4 | 22424883 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SIN3B BAZ2B NASP RREB1 ARHGAP11A TRIP12 RLF GTF3C1 PHF3 ARID2 NIPBL ZMYM4 KIFC1 | 2.66e-05 | 608 | 186 | 13 | 36089195 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.72e-05 | 361 | 186 | 10 | 26167880 | |
| Pubmed | 2.84e-05 | 2 | 186 | 2 | 19062096 | ||
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 2.84e-05 | 2 | 186 | 2 | 15963947 | |
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 2.84e-05 | 2 | 186 | 2 | 30044367 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 2.84e-05 | 2 | 186 | 2 | 17645767 | |
| Pubmed | 2.84e-05 | 2 | 186 | 2 | 15131124 | ||
| Pubmed | 2.84e-05 | 2 | 186 | 2 | 12207352 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 2.84e-05 | 2 | 186 | 2 | 27758680 | |
| Pubmed | Two independent modes of chromatin organization revealed by cohesin removal. | 2.84e-05 | 2 | 186 | 2 | 29094699 | |
| Pubmed | 2.84e-05 | 2 | 186 | 2 | 37085264 | ||
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 2.84e-05 | 2 | 186 | 2 | 20404337 | |
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 2.84e-05 | 2 | 186 | 2 | 3037333 | |
| Pubmed | 2.84e-05 | 2 | 186 | 2 | 11726230 | ||
| Pubmed | 2.84e-05 | 2 | 186 | 2 | 4216347 | ||
| Interaction | NTN5 interactions | 2.05e-06 | 24 | 181 | 5 | int:NTN5 | |
| Interaction | IGFL3 interactions | 4.98e-06 | 75 | 181 | 7 | int:IGFL3 | |
| GeneFamily | Complement system|Sushi domain containing | 2.01e-07 | 36 | 130 | 6 | 492 | |
| GeneFamily | Wnt family|Endogenous ligands | 9.10e-06 | 19 | 130 | 4 | 360 | |
| GeneFamily | Low density lipoprotein receptors | 9.86e-05 | 13 | 130 | 3 | 634 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 3.30e-04 | 46 | 130 | 4 | 622 | |
| GeneFamily | ADAMTS like | 1.05e-03 | 7 | 130 | 2 | 947 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.79e-03 | 9 | 130 | 2 | 1234 | |
| GeneFamily | CD molecules|Integrin beta subunits | 1.79e-03 | 9 | 130 | 2 | 1159 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 2.36e-03 | 37 | 130 | 3 | 454 | |
| GeneFamily | Immunoglobulin like domain containing | 2.73e-03 | 193 | 130 | 6 | 594 | |
| GeneFamily | PHD finger proteins | 4.05e-03 | 90 | 130 | 4 | 88 | |
| Coexpression | MARTIN_VIRAL_GPCR_SIGNALING_UP | 1.83e-07 | 86 | 186 | 8 | M1327 | |
| Coexpression | NABA_MATRISOME | SEMA3F RELN SEMA7A WNT5A WNT7B WNT8B PAPLN ADAM30 COL22A1 ADAM11 ADAMTSL3 SVEP1 WNT5B MST1 EYS FBN1 FBN2 HMCN2 ADAMTS6 SBSPON ADAMTS15 CLEC3B MST1L | 1.15e-06 | 1026 | 186 | 23 | M5889 |
| Coexpression | GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN | PDE3B ZBTB17 BAZ2B SRPRA TSPYL1 MED13L ITGB1 HEXIM1 ZNF827 GKAP1 | 1.42e-06 | 195 | 186 | 10 | M7310 |
| Coexpression | NABA_MATRISOME | SEMA3F RELN SEMA7A WNT5A WNT7B WNT8B PAPLN ADAM30 COL22A1 ADAM11 ADAMTSL3 SVEP1 WNT5B MST1 FBN1 FBN2 HMCN2 ADAMTS6 SBSPON ADAMTS15 CLEC3B MST1L | 3.08e-06 | 1008 | 186 | 22 | MM17056 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP34 BAZ2B WNT5A MED13L TRAPPC8 ARHGAP11A ZZEF1 TRIP12 RLF SLC7A1 LRPPRC PHF3 SYNE2 MACF1 MTCL1 KAT6B STK24 NIPBL ZMYM4 MYBL1 | 3.26e-06 | 856 | 186 | 20 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | BAZ2B WNT5A MED13L TRAPPC8 TRIP12 SLC7A1 LRPPRC PHF3 MTCL1 KAT6B STK24 ZMYM4 MYBL1 | 3.09e-05 | 466 | 186 | 13 | M13522 |
| Coexpression | DESCARTES_FETAL_THYMUS_VASCULAR_ENDOTHELIAL_CELLS | 4.31e-05 | 131 | 186 | 7 | M40316 | |
| Coexpression | HALLMARK_COAGULATION | 6.00e-05 | 138 | 186 | 7 | M5946 | |
| Coexpression | AMIT_EGF_RESPONSE_20_MCF10A | 7.38e-05 | 12 | 186 | 3 | M4625 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_UP | 7.56e-05 | 32 | 186 | 4 | M40934 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 8.31e-05 | 196 | 186 | 8 | M3008 | |
| Coexpression | GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP | 8.31e-05 | 196 | 186 | 8 | M3243 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | SEMA3F LDLRAP1 RELN PRR5L KIF26B WNT5A BHLHA9 IRF8 THSD7B ARHGAP11A SVEP1 STAC2 PTPRB SALL1 PPP1R1B PPM1L ADAMTS15 LRP5 MYO16 NOTCH1 | 8.33e-05 | 1074 | 186 | 20 | M1941 |
| Coexpression | GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP | 9.57e-05 | 200 | 186 | 8 | M7283 | |
| Coexpression | VANTVEER_BREAST_CANCER_ESR1_UP | 9.72e-05 | 149 | 186 | 7 | M393 | |
| Coexpression | KYNG_DNA_DAMAGE_UP | 1.14e-04 | 205 | 186 | 8 | M3961 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2C | RELN RHOJ LRP1B ITGB8 TRIM67 NRXN1 ADAMTS6 LRP1 CSMD1 NOTCH1 | 1.17e-04 | 325 | 186 | 10 | M39053 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN STAB2 KIF26B SPTA1 COL22A1 LRP1B PKHD1L1 FBN2 NRXN1 PCDH15 CSMD1 MYO16 | 2.05e-11 | 184 | 186 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN STAB2 KIF26B SPTA1 COL22A1 LRP1B PKHD1L1 FBN2 NRXN1 PCDH15 CSMD1 MYO16 | 2.05e-11 | 184 | 186 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN STAB2 KIF26B SPTA1 COL22A1 LRP1B PKHD1L1 FBN2 NRXN1 PCDH15 CSMD1 MYO16 | 2.05e-11 | 184 | 186 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | RELN STAB2 PRR5L RHOJ TNFRSF11A PKHD1L1 FBN1 PTPRB ADAMTS15 FAM43A | 5.29e-09 | 182 | 186 | 10 | 41b070085edba7a58b81c20aa4942d06f745acf8 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | RELN STAB2 PRR5L RHOJ TNFRSF11A PKHD1L1 FBN1 PTPRB ADAMTS15 FAM43A | 5.29e-09 | 182 | 186 | 10 | 5e9a67b2de0daa4fdc344b10a857d8a901ad810e |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | RELN STAB2 PRR5L RHOJ TNFRSF11A PKHD1L1 FBN1 PTPRB ADAMTS15 FAM43A | 5.29e-09 | 182 | 186 | 10 | b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 7.22e-09 | 188 | 186 | 10 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | RELN STAB2 RHOJ KIF26B TNFRSF11A PKHD1L1 EYS PTPRB VAV3 FAM43A | 7.22e-09 | 188 | 186 | 10 | 2db80767903703e7e0a1a37c598f7877a909ee94 |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-6_VIP_PENK|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.11e-08 | 169 | 186 | 9 | eb3b8e473192c4b8688f2f8da400116dd6fe193d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1-2_PAX6_SCGN|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.02e-08 | 173 | 186 | 9 | 33170a1cc0bc87504d0501fc257a32ff17e02314 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.13e-08 | 183 | 186 | 9 | bc98df870de65aff6dab295c24cbc199c7f2aa15 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 9.78e-08 | 187 | 186 | 9 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor | 9.78e-08 | 187 | 186 | 9 | 1e52d3d9d664c813d859b5b75e4c07b218818f95 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-07 | 188 | 186 | 9 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.02e-07 | 188 | 186 | 9 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.07e-07 | 189 | 186 | 9 | 55a1776a4ce049959b3f13a43744c7314bc1f00a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | RELN STAB2 PRR5L RHOJ TNFRSF11A PKHD1L1 FBN1 ADAMTS15 FAM43A | 1.12e-07 | 190 | 186 | 9 | 876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | RELN STAB2 PRR5L RHOJ TNFRSF11A PKHD1L1 FBN1 ADAMTS15 FAM43A | 1.12e-07 | 190 | 186 | 9 | 09a8855901c3c9332dbaab3e40166485b696d0f1 |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel|Adult / Lineage, Cell type, age group and donor | RELN STAB2 RHOJ TNFRSF11A ADAMTSL3 PKHD1L1 PTPRB VAV3 FAM43A | 1.12e-07 | 190 | 186 | 9 | 91bf3b7e9148589757436a53a4f58e0ebfe54400 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | RELN STAB2 PRR5L RHOJ TNFRSF11A PKHD1L1 FBN1 ADAMTS15 FAM43A | 1.12e-07 | 190 | 186 | 9 | be9f36127028f52ca5fc1b32ba15a6c26aad69ac |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.40e-07 | 195 | 186 | 9 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.73e-07 | 200 | 186 | 9 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-07 | 200 | 186 | 9 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.11e-07 | 148 | 186 | 8 | 5729826e8d45bf995e2efa6707c49e264d12d112 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.21e-07 | 162 | 186 | 8 | 2ac02523348660e514d464f8f2434ee0c312d784 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.07e-07 | 166 | 186 | 8 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | Endothelial-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 5.80e-07 | 169 | 186 | 8 | 8889c9e8af1ab0b093d57b69abd80b59b3461be9 | |
| ToppCell | Endothelial-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 5.80e-07 | 169 | 186 | 8 | 95c617143e1fbdd1d55a93ffdcc210e0be37cf2f | |
| ToppCell | Endothelial-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 6.35e-07 | 171 | 186 | 8 | 07ff7059071da83da1d8f266a586573920d75b58 | |
| ToppCell | PSB-critical-LOC-Lymphoid-B_cell|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.63e-07 | 172 | 186 | 8 | 57b91bcce3f122f3d3267cf4d3a3ef67842caa9a | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 6.93e-07 | 173 | 186 | 8 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.93e-07 | 173 | 186 | 8 | 9dc7746a84f0e268a7c061e1bbcd5e31903034dc | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Lymphatic_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 7.24e-07 | 174 | 186 | 8 | d551bc29afef071adf4c9bb80345352ec33441d8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.56e-07 | 175 | 186 | 8 | 9a96a946db731ba24c9be34bedebf1f4a1372b9e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.56e-07 | 175 | 186 | 8 | 2b51406a2c2daa13ab4ed283ede038cd11d9e641 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.56e-07 | 175 | 186 | 8 | 54c1f080195ad8392a095e83b56a4b54073d4c0d | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.23e-07 | 177 | 186 | 8 | d6596a0b6fd146fefc27717c1a7dbaa3774cc644 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.96e-07 | 179 | 186 | 8 | dfd5b25f2a6a5a8bf4714f1516cb0997de72b06f | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.74e-07 | 181 | 186 | 8 | 330d4322f4c4373f706273c1f4e218b59051b7fd | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.74e-07 | 181 | 186 | 8 | 3f4d5d79c1286614514b0e8134079d6128a2a23e | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.14e-06 | 128 | 186 | 7 | 91072ca56bce2c552a95edd67e17f43d8cc1de95 | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.15e-06 | 185 | 186 | 8 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.15e-06 | 185 | 186 | 8 | f9f48251bc33eb6bf2cff580d1a3207d21450aa0 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.15e-06 | 185 | 186 | 8 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-06 | 186 | 186 | 8 | 055cc23c4db9aad2d6c62e62c8e58bfe5047c6b1 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.20e-06 | 186 | 186 | 8 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|kidney / Disease (COVID-19 only), tissue and cell type | 1.20e-06 | 129 | 186 | 7 | 57b705106aec7bbfc587de1ccd4f2335fc44dd6f | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.24e-06 | 187 | 186 | 8 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.24e-06 | 187 | 186 | 8 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | moderate-Epithelial-Ionocyte|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.24e-06 | 187 | 186 | 8 | 3e3fe2d5712a0ac477cddefe56705d4b8d8f7eac | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.30e-06 | 188 | 186 | 8 | c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0 | |
| ToppCell | Endothelial-endothelial_cell_of_lymph_vessel|World / Lineage, Cell type, age group and donor | 1.30e-06 | 188 | 186 | 8 | 80910dcbb51990f2baed240f319456c0d3fa2065 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.30e-06 | 188 | 186 | 8 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.35e-06 | 189 | 186 | 8 | 0d18ea72bd58d32a8ab9a61cf97f5786642f804b | |
| ToppCell | COVID-19-lung-Lymphatic_EC|lung / Disease (COVID-19 only), tissue and cell type | 1.35e-06 | 189 | 186 | 8 | c8db9aaf54ea3cc96c4a2f777c3389e0f31f67f3 | |
| ToppCell | moderate-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.35e-06 | 189 | 186 | 8 | 6011b747e27d61d222380a7bffdd921a68e9b657 | |
| ToppCell | wk_08-11-Endothelial-Lymph_endothelial-Lymphatic_endo|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.40e-06 | 190 | 186 | 8 | 279c5f68b993dc7adbf9aa69fffb1321cdebc48a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-06 | 190 | 186 | 8 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | wk_08-11-Endothelial-Lymph_endothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.40e-06 | 190 | 186 | 8 | d7f1dc032d161529559e01832d1a3112c6f6cc1a | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 191 | 186 | 8 | 9d3fa8d8138700640cc7927521c7635299df697d | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 191 | 186 | 8 | d04ed1e04b8cb904237d8e8388fe7740c724237b | |
| ToppCell | (1)_Control_(PBS)|World / Stress and Cell class | 1.46e-06 | 191 | 186 | 8 | b346e13259cb2d506b923ad44b894c21a3eee4c3 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.46e-06 | 191 | 186 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-06 | 192 | 186 | 8 | 5e709c0714e8eba27e03a6def0544256bedb3ced | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-06 | 192 | 186 | 8 | 5f4f44f15d3a2846981e68296643a4634930a211 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-06 | 192 | 186 | 8 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.52e-06 | 192 | 186 | 8 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Control-NK_CD56bright|Control / Disease condition and Cell class | 1.58e-06 | 193 | 186 | 8 | 8b1e7a226a6057e1097c1525984127b54e823876 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.58e-06 | 193 | 186 | 8 | a594f89a18273797506287d9e22f72abe53e4920 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.58e-06 | 193 | 186 | 8 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.58e-06 | 193 | 186 | 8 | ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.58e-06 | 193 | 186 | 8 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.58e-06 | 193 | 186 | 8 | e787e618f6e8a1e22be366ce606bf78831b60a90 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 1.58e-06 | 193 | 186 | 8 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.58e-06 | 193 | 186 | 8 | 30481fb01c7acf85beae10213f038da86bed6777 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-06 | 194 | 186 | 8 | 83863da11dfbe59b2d0a2c08db40b537c150588c | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 1.64e-06 | 194 | 186 | 8 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | IPF-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 1.70e-06 | 195 | 186 | 8 | de88e9d22044b4b3e29676ad02b3e9299cc920ad | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.70e-06 | 195 | 186 | 8 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 196 | 186 | 8 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 196 | 186 | 8 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | Endothelial_cells-Endothelial-B|Endothelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.77e-06 | 196 | 186 | 8 | 36f95f9ef74eb951e41ef46fd136ceaef45208fc | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.77e-06 | 196 | 186 | 8 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 1.84e-06 | 197 | 186 | 8 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 1.84e-06 | 197 | 186 | 8 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.91e-06 | 198 | 186 | 8 | 9ab0db78394e730f6866b2db80047149024ad5f6 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.91e-06 | 198 | 186 | 8 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.91e-06 | 198 | 186 | 8 | e47d0e2c6353315c85d7007742bb16b0f05795ed | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 2.06e-06 | 200 | 186 | 8 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.06e-06 | 200 | 186 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-06 | 200 | 186 | 8 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.06e-06 | 200 | 186 | 8 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.06e-06 | 200 | 186 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | mild-NK|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.06e-06 | 200 | 186 | 8 | a11fb1d7e124c352eb73fea0e0ec0fed577c97f7 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 2.06e-06 | 200 | 186 | 8 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-06 | 200 | 186 | 8 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 2.06e-06 | 200 | 186 | 8 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-06 | 200 | 186 | 8 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.06e-06 | 200 | 186 | 8 | ac8a5d71acd4d401995babd233f0d3738e8ad2a5 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 2.06e-06 | 200 | 186 | 8 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| Computational | Complement. | 5.58e-06 | 23 | 125 | 5 | MODULE_130 | |
| Computational | Genes in the cancer module 58. | 8.95e-05 | 21 | 125 | 4 | MODULE_58 | |
| Drug | Methocarbamol [532-03-6]; Down 200; 16.6uM; MCF7; HT_HG-U133A | PDE3B ZBTB17 WNT7B EML2 CFD ARFRP1 TRNAU1AP ZNF480 MTCL1 AKAP7 PHTF1 | 5.72e-07 | 195 | 184 | 11 | 7467_DN |
| Drug | Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A | SEMA3F PDE3B SEMA7A TRAIP APAF1 EML2 SLC7A1 CARD9 MCM3AP SMG6 | 4.05e-06 | 193 | 184 | 10 | 3845_UP |
| Drug | Sulfamethizole [144-82-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A | USP34 PDE3B ZBTB17 NASP ARHGAP11A CFD ARFRP1 METTL16 KAT6B NOTCH1 | 4.24e-06 | 194 | 184 | 10 | 6272_DN |
| Disease | Complement deficiency disease | 4.89e-08 | 33 | 182 | 6 | C0272242 | |
| Disease | Noonan syndrome (implicated_via_orthology) | 9.19e-07 | 4 | 182 | 3 | DOID:3490 (implicated_via_orthology) | |
| Disease | Antibody Deficiency Syndrome | 3.13e-06 | 17 | 182 | 4 | C0003257 | |
| Disease | Immunologic Deficiency Syndromes | 1.13e-05 | 23 | 182 | 4 | C0021051 | |
| Disease | body weight | RELN ZBTB38 WNT7B NUP88 THSD7B ADAMTSL3 ZZEF1 APOBR TRIP12 LRP1B GHR SLC7A1 EYS FBN2 NRXN1 PHF3 PCDH15 KAT6B NIPBL COG4 AKAP7 | 3.64e-05 | 1261 | 182 | 21 | EFO_0004338 |
| Disease | body surface area | ZBTB38 MCPH1 MED13L RREB1 ADAMTSL3 TRIP12 ITGB8 GHR FBN1 FBN2 SLCO1C1 MACF1 FUBP3 AKAP7 | 4.96e-05 | 643 | 182 | 14 | EFO_0022196 |
| Disease | Crohn's disease | KIF21B USP34 ZBTB38 MAGI3 ADAM30 MST1 CARD9 SBSPON USP1 NOTCH1 PHTF1 | 9.98e-05 | 441 | 182 | 11 | EFO_0000384 |
| Disease | multiple system atrophy | 1.08e-04 | 40 | 182 | 4 | EFO_1001050 | |
| Disease | Neisseriaceae Infections | 1.13e-04 | 3 | 182 | 2 | C0085396 | |
| Disease | connective tissue disease (implicated_via_orthology) | 1.13e-04 | 3 | 182 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | bone density | ZBTB17 TNFRSF11A MED13L RREB1 WNT5B FBN2 LRP5 MTCL1 FUBP3 SMG6 | 1.59e-04 | 388 | 182 | 10 | EFO_0003923 |
| Disease | C-reactive protein measurement | SEMA3F USP34 OR10J3 CARMIL1 WNT7B TRAIP CYP26A1 FAM220A SOCS3 EML2 RREB1 CBL ZZEF1 TRIP12 SALL1 CARD9 PCDH15 MACF1 AKAP7 | 1.79e-04 | 1206 | 182 | 19 | EFO_0004458 |
| Disease | scoliosis (is_implicated_in) | 2.25e-04 | 4 | 182 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | response to steroid, systemic lupus erythematosus, idiopathic osteonecrosis of the femoral head | 2.25e-04 | 4 | 182 | 2 | EFO_0020976, EFO_1001930, MONDO_0007915 | |
| Disease | body fat percentage | RELN ZBTB38 APAF1 NUP88 ADAMTSL3 ZZEF1 TRIP12 NRXN1 LRP1 MACF1 STK24 | 2.40e-04 | 488 | 182 | 11 | EFO_0007800 |
| Disease | vital capacity | USP34 ZBTB38 MYH7B RREB1 ADAMTSL3 ZZEF1 TRIP12 ITGB8 SVEP1 TMEFF1 GHR ADAMTS6 CARD9 ADAMTS15 MTCL1 COG4 MYO16 AKAP7 SMG6 | 2.43e-04 | 1236 | 182 | 19 | EFO_0004312 |
| Disease | childhood onset asthma | ZBTB38 PRR5L TNFRSF11A ITGB8 HEXIM1 STAC2 ARFRP1 PPP1R1B LRP1 | 2.44e-04 | 334 | 182 | 9 | MONDO_0005405 |
| Disease | cortical surface area measurement | USP34 RELN MCPH1 BAZ2B KIF26B EML2 COL22A1 MED13L RREB1 ADAMTSL3 ITGB8 SVEP1 CELSR1 FBN1 FBN2 NAV2 MACF1 MTCL1 MYO16 SMG6 | 2.56e-04 | 1345 | 182 | 20 | EFO_0010736 |
| Disease | social interaction measurement | 2.98e-04 | 94 | 182 | 5 | EFO_0009592 | |
| Disease | response to sertraline, psychotic symptom measurement, response to olanzapine | 3.74e-04 | 5 | 182 | 2 | EFO_0006327, EFO_0009182, GO_0097333 | |
| Disease | adult T-cell leukemia/lymphoma (is_implicated_in) | 3.74e-04 | 5 | 182 | 2 | DOID:0050523 (is_implicated_in) | |
| Disease | airway responsiveness measurement | 4.25e-04 | 24 | 182 | 3 | EFO_0006897 | |
| Disease | Dermatomyositis, Childhood Type | 5.58e-04 | 6 | 182 | 2 | C0263666 | |
| Disease | Adult type dermatomyositis | 5.58e-04 | 6 | 182 | 2 | C0221056 | |
| Disease | Dermatomyositis | 5.58e-04 | 6 | 182 | 2 | C0011633 | |
| Disease | corneal topography | 5.88e-04 | 109 | 182 | 5 | EFO_0004345 | |
| Disease | lumbar disc degeneration | 6.75e-04 | 28 | 182 | 3 | EFO_0004994 | |
| Disease | Eczema | 7.15e-04 | 310 | 182 | 8 | HP_0000964 | |
| Disease | muscular atrophy (biomarker_via_orthology) | 7.49e-04 | 29 | 182 | 3 | DOID:767 (biomarker_via_orthology) | |
| Disease | growth differentiation factor 15 measurement | 7.79e-04 | 7 | 182 | 2 | EFO_0009181 | |
| Disease | juvenile myelomonocytic leukemia (is_implicated_in) | 7.79e-04 | 7 | 182 | 2 | DOID:0050458 (is_implicated_in) | |
| Disease | schizophrenia (implicated_via_orthology) | 8.38e-04 | 68 | 182 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | spontaneous coronary artery dissection | 9.14e-04 | 31 | 182 | 3 | EFO_0010820 | |
| Disease | osteoporosis (is_implicated_in) | 9.14e-04 | 31 | 182 | 3 | DOID:11476 (is_implicated_in) | |
| Disease | Lupus Erythematosus, Systemic | 9.86e-04 | 71 | 182 | 4 | C0024141 | |
| Disease | neuroimaging measurement | KIF21B RELN MCPH1 KIF26B CARMIL1 EML2 COL22A1 RREB1 STAC2 CELSR1 FBN2 PPP1R1B NAV2 MACF1 MYO16 SMG6 | 1.01e-03 | 1069 | 182 | 16 | EFO_0004346 |
| Disease | neurexophilin-1 measurement | 1.03e-03 | 8 | 182 | 2 | EFO_0008244 | |
| Disease | triacylglycerol 58:6 measurement | 1.03e-03 | 8 | 182 | 2 | EFO_0010440 | |
| Disease | Fanconi anemia (implicated_via_orthology) | 1.03e-03 | 8 | 182 | 2 | DOID:13636 (implicated_via_orthology) | |
| Disease | Familial hypercholesterolemia | 1.03e-03 | 8 | 182 | 2 | cv:C0020445 | |
| Disease | peak expiratory flow | ZBTB38 CARMIL1 TRAIP SLC26A9 RREB1 ADAMTSL3 EYS LRP1 LRP5 MTCL1 | 1.11e-03 | 498 | 182 | 10 | EFO_0009718 |
| Disease | vitamin D measurement | 1.20e-03 | 336 | 182 | 8 | EFO_0004631 | |
| Disease | IGA Glomerulonephritis | 1.20e-03 | 34 | 182 | 3 | C0017661 | |
| Disease | chronotype measurement | USP34 RELN KIF21A COL22A1 MED13L LRPPRC NRXN1 ARID2 PPM1L GKAP1 PCDH15 CSMD1 MYO16 JHY | 1.20e-03 | 882 | 182 | 14 | EFO_0008328 |
| Disease | Liver carcinoma | 1.27e-03 | 507 | 182 | 10 | C2239176 | |
| Disease | forced expiratory volume | ZBTB38 CARMIL1 TRAIP ADAMTSL3 ITGB8 SVEP1 EYS ARFRP1 CARD9 PCDH15 LRP5 MTCL1 COG4 | 1.29e-03 | 789 | 182 | 13 | EFO_0004314 |
| Disease | atopic eczema, psoriasis | 1.42e-03 | 36 | 182 | 3 | EFO_0000274, EFO_0000676 | |
| Disease | interleukin 4 measurement | 1.42e-03 | 36 | 182 | 3 | EFO_0008184 | |
| Disease | alkaline phosphatase measurement | USP34 CARMIL1 PAPLN TNFRSF11A RREB1 ZNF827 ZNF45 MYLK4 MACF1 PRR14L FUBP3 CLUH COG4 NOTCH1 PHTF1 | 1.64e-03 | 1015 | 182 | 15 | EFO_0004533 |
| Disease | aortic aneurysm | 1.65e-03 | 10 | 182 | 2 | EFO_0001666 | |
| Disease | hepatocyte growth factor-like protein measurement | 1.66e-03 | 38 | 182 | 3 | EFO_0008154 | |
| Disease | urate measurement, bone density | PDE3B BAZ2B CARMIL1 MAGI3 EYS SALL1 C2 KAT6B MYO16 JHY LRRFIP2 | 1.68e-03 | 619 | 182 | 11 | EFO_0003923, EFO_0004531 |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.92e-03 | 447 | 182 | 9 | EFO_0000694, MONDO_0100096 | |
| Disease | total blood protein measurement | 1.97e-03 | 449 | 182 | 9 | EFO_0004536 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 1.98e-03 | 364 | 182 | 8 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | carotid artery intima media thickness | 2.00e-03 | 450 | 182 | 9 | EFO_0007117 | |
| Disease | Congenital Abnormality | 2.01e-03 | 11 | 182 | 2 | C0000768 | |
| Disease | kidney cancer | 2.01e-03 | 11 | 182 | 2 | MONDO_0002367 | |
| Disease | osteosarcoma (is_marker_for) | 2.01e-03 | 11 | 182 | 2 | DOID:3347 (is_marker_for) | |
| Disease | colorectal cancer, hormone replacement therapy | 2.18e-03 | 88 | 182 | 4 | EFO_0003961, MONDO_0005575 | |
| Disease | smoking status measurement, chronic obstructive pulmonary disease | 2.18e-03 | 88 | 182 | 4 | EFO_0000341, EFO_0006527 | |
| Disease | Eczema, allergic rhinitis | 2.24e-03 | 215 | 182 | 6 | EFO_0005854, HP_0000964 | |
| Disease | fibromuscular dysplasia | 2.54e-03 | 44 | 182 | 3 | EFO_1000938 | |
| Disease | diffuse plaque measurement | RELN PRR5L KIF26B COL22A1 LRP1B EYS FBN2 SBSPON MYLK4 MACF1 KAT6B MYO16 | 2.73e-03 | 758 | 182 | 12 | EFO_0010699 |
| Disease | response to hydrochlorothiazide, fasting blood glucose measurement | 2.88e-03 | 46 | 182 | 3 | EFO_0004465, EFO_0005202 | |
| Disease | central corneal thickness | 3.18e-03 | 309 | 182 | 7 | EFO_0005213 | |
| Disease | asymmetric dimethylarginine measurement | 3.28e-03 | 14 | 182 | 2 | EFO_0010463 | |
| Disease | Alzheimer disease, visuospatial impairment | 3.28e-03 | 14 | 182 | 2 | EFO_0009752, MONDO_0004975 | |
| Disease | Endometrioma | 3.30e-03 | 161 | 182 | 5 | C0269102 | |
| Disease | Endometriosis | 3.30e-03 | 161 | 182 | 5 | C0014175 | |
| Disease | ceramide measurement | 3.48e-03 | 235 | 182 | 6 | EFO_0010222 | |
| Disease | forehead morphology measurement | 3.77e-03 | 15 | 182 | 2 | EFO_0007844 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 3.77e-03 | 15 | 182 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | cortical thickness | RELN MCPH1 EML2 RREB1 ADAMTSL3 CELSR1 FBN1 FBN2 LRP1 NAV2 MACF1 MTCL1 CLUH MYO16 SMG6 | 3.90e-03 | 1113 | 182 | 15 | EFO_0004840 |
| Disease | FEV/FEC ratio | USP34 BHLHA9 NASP SLC26A9 RREB1 ADAMTSL3 ITGB8 FBN1 SBSPON SYNE2 LRP1 NAV2 MTCL1 CSMD1 MYO16 SMG6 | 4.02e-03 | 1228 | 182 | 16 | EFO_0004713 |
| Disease | refractive error | 4.25e-03 | 326 | 182 | 7 | MONDO_0004892 | |
| Disease | decreased susceptibility to hepatitis C infection | 4.29e-03 | 16 | 182 | 2 | EFO_0010101 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 4.31e-03 | 53 | 182 | 3 | C4707243 | |
| Disease | response to cisplatin, platinum measurement | 4.31e-03 | 53 | 182 | 3 | EFO_0010154, GO_0072718 | |
| Disease | serum selenium measurement | 4.31e-03 | 53 | 182 | 3 | EFO_0005266 | |
| Disease | hepcidin:ferritin ratio | 4.79e-03 | 55 | 182 | 3 | EFO_0007901 | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 4.84e-03 | 17 | 182 | 2 | OBA_2045173 | |
| Disease | hemoglobin A1 measurement | 5.17e-03 | 520 | 182 | 9 | EFO_0007629 | |
| Disease | cup-to-disc ratio measurement | 5.41e-03 | 430 | 182 | 8 | EFO_0006939 | |
| Disease | Age-related macular degeneration | 5.42e-03 | 18 | 182 | 2 | cv:C0242383 | |
| Disease | adverse effect, response to xenobiotic stimulus | 5.82e-03 | 59 | 182 | 3 | EFO_0009658, GO_0009410 | |
| Disease | Chronic myeloproliferative disorder | 6.04e-03 | 19 | 182 | 2 | C1292778 | |
| Disease | Juvenile Myelomonocytic Leukemia | 6.04e-03 | 19 | 182 | 2 | C0349639 | |
| Disease | response to antipsychotic drug | 6.10e-03 | 60 | 182 | 3 | GO_0097332 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GKQEGAGSCQREAAR | 161 | Q8N6Y0 | |
| ADGCSLRDANTNRKG | 251 | Q6ZR03 | |
| DGQRIASCGADKTLQ | 626 | O14727 | |
| NSAEGAGLTDNGCRR | 266 | Q86US8 | |
| VAECGASVKGNEGTL | 1101 | Q96PZ7 | |
| GNRDAGECNKRDNTS | 66 | Q9NQI0 | |
| LGSLGAACEQTQTEG | 521 | P07357 | |
| NSLRVDVQAGACEGK | 556 | P0C0L5 | |
| AGGINSNECENVSRK | 6 | Q9P0M2 | |
| GIGGEQAQAKFDSCL | 576 | Q9H9E3 | |
| VLGANGASCSRGEAE | 36 | Q7RTU4 | |
| KSTSSGGGNRKCNQE | 201 | Q9UIF8 | |
| CLAQVQQAGGGDSDK | 11 | Q7Z4H9 | |
| QQAGGGDSDKLSCSL | 16 | Q7Z4H9 | |
| LNVEGTERGSCGRKG | 571 | O75078 | |
| CRRGATNTSNGDTKE | 1271 | Q68CP9 | |
| QGGRKGKRNSESDQC | 351 | Q5VSY0 | |
| DARSGRCANGVCKNG | 1401 | Q9NYQ6 | |
| CGESEVAGATATKNG | 526 | Q8TF21 | |
| DTQLSDKGCLAGGGS | 446 | Q9H257 | |
| LCKNRDVSNLESSGG | 1416 | Q96F81 | |
| SIDTSCEGELQVGKG | 41 | Q96JC9 | |
| GDNINTARAIAAKCG | 706 | Q16720 | |
| GSGLQKRAVDCRGSA | 856 | Q8TE58 | |
| AAEGTLCQTGNIEKG | 526 | Q9UKP5 | |
| NGTGENGRKCSNISI | 406 | P05556 | |
| SQLGKGNFGSVELCR | 826 | P52333 | |
| RGGSFLCDQKDGNVR | 1281 | Q9Y4B5 | |
| SAKGSRGSCNDLRNV | 91 | Q8WYB5 | |
| SQEGGDVLGARQDCT | 186 | Q5SW96 | |
| AESNRRDSCKGDSGG | 196 | P00746 | |
| CAEGNLVVAGSGDLS | 436 | Q5XUX1 | |
| ESGNLKNSERCQGRT | 451 | P23467 | |
| CLNGGKCEAANGTEA | 31 | P46531 | |
| DGSDEKGCNGTIRLC | 1081 | Q9NZR2 | |
| EKGTNVCARDNGGCK | 2141 | Q9NZR2 | |
| ISADRTQGNIGCGGD | 1621 | Q71F56 | |
| GENKSCQVSTRAGSG | 1261 | Q5TCQ9 | |
| NSGCGNQERKLEGSI | 241 | Q8NEM0 | |
| LTEFGAKGGSNVGDC | 2881 | Q5T1H1 | |
| NSTGCDSGLNVNKER | 456 | Q6NUN7 | |
| RGSCTLGREGQADAK | 171 | Q68DU8 | |
| KAGSQFLCNGGSRAT | 1556 | Q6PRD1 | |
| QEATSVSCFRGKGEG | 246 | Q2TV78 | |
| QCFILSGERGSGKSE | 491 | Q9Y6X6 | |
| ESRCQQGKTQFGVGL | 51 | Q8IZA0 | |
| GEIRNVGTGLCADTK | 461 | Q86SR1 | |
| DGKACTSLERNGQNV | 4791 | Q8NDA2 | |
| DRQKGTNVCAVANGG | 2151 | Q07954 | |
| LVLTGSSERECQGNG | 181 | P06681 | |
| KNREGGSGLCLSLSA | 721 | Q2KJY2 | |
| SQGGCRVQDKDNSGA | 91 | B1AK53 | |
| SKAGVRQGCEEAVSQ | 266 | O60318 | |
| GVQLQDNGRTCKAGA | 326 | O75197 | |
| GSNTCLAKVDLSGNG | 566 | Q8ND23 | |
| ESSCLREGEKGQNGD | 81 | O94992 | |
| DLLATGTRKGQGGEC | 471 | Q9BW19 | |
| EAGGASAGQREGCRK | 1201 | A7E2Y1 | |
| AINRKEGICALGGTS | 96 | P13797 | |
| FNLVAKATDGGGRSC | 3081 | Q9NYQ8 | |
| KATDGGGRSCQADIT | 3086 | Q9NYQ8 | |
| QLAEEAGKSCGAGSV | 376 | Q02556 | |
| IGSGGERAKALNTCV | 226 | Q9H340 | |
| ATGEGRKKALNTCGS | 231 | Q9H342 | |
| FLSAKCLQGNADGDG | 711 | Q9Y5F6 | |
| GCGTGNETDSDGRIN | 766 | Q13370 | |
| TGERAKEGISINCGL | 286 | O75037 | |
| GGEQISRIQAESGCK | 96 | Q96I24 | |
| DSDNKGVNSGRLVAC | 1991 | Q6KC79 | |
| CFLEKNSGDQDSRSG | 36 | Q86YV6 | |
| ASVQEGGKDSCQGDS | 221 | Q9UBX7 | |
| KGGVEVLESCQGSSN | 471 | Q86W50 | |
| QKVFNDTCRSGGLGG | 106 | P42704 | |
| KEGFQGCLASVDLNG | 1046 | Q9ULB1 | |
| GAAGTQGRKSAACGQ | 16 | Q8NF86 | |
| GTDSSCGCRGNDEKK | 6 | Q9H4E5 | |
| SGTDVQEECREKGGQ | 246 | P49321 | |
| QKCSRNDGTVGDLAG | 596 | Q9Y608 | |
| GLGQGLIQSAGKDCD | 5296 | Q9UPN3 | |
| AAVANRAKGGGCECE | 316 | Q9NYA4 | |
| ASAGKGCEGNSRELS | 1341 | P78509 | |
| CNDQSTGDIKVIGGD | 106 | P00492 | |
| CSERGGGVNFGEKDA | 16 | E2RYF7 | |
| NCSGLGSRQLAGDSK | 181 | Q99489 | |
| EGARGSQEGSELNCA | 351 | Q6MZQ0 | |
| GRALQTFGACKGNGE | 266 | Q9UHM6 | |
| VLGLGQGEDNRCASS | 36 | P26012 | |
| KAENENTGICTNKRG | 1606 | Q96QU1 | |
| RDRDSGNNGKTVCSI | 371 | Q9Y5E2 | |
| LLDQSAKDCSQERGG | 281 | Q1HG44 | |
| INDGTSCGEGRVCFK | 606 | Q9UKF2 | |
| QACSALTGKGVREGI | 166 | Q13795 | |
| CQSRSDLLKAGGGAG | 236 | Q8WXS5 | |
| SSSGGDCNQDKSRDL | 1811 | Q9Y2F5 | |
| GRKGQEGESCLRTFD | 136 | Q9UBT3 | |
| NLGVKDGDSGRTSCC | 376 | P10912 | |
| GDNAVLQCLKGTSDG | 31 | P15391 | |
| RGDNGDTACSNEIGV | 1541 | P35555 | |
| LGTKAACGKVRGSEN | 1001 | Q8NFW1 | |
| GNATTIQARGDGCTD | 76 | Q8N2R8 | |
| IQARGDGCTDLAVGK | 81 | Q8N2R8 | |
| ATCQFLSGENKTLGG | 176 | Q6UX82 | |
| SQGLNLGCRGTLSDE | 26 | O43504 | |
| GDGCRSQGSRNSEKA | 456 | Q9H9L4 | |
| GIRGSGAKAVCSNEV | 361 | Q96G42 | |
| RNCGGDAIQEDLKSA | 706 | Q5VZK9 | |
| INSERKAGSCQQGSG | 831 | P22681 | |
| CGLRASEAGQGCKDA | 256 | O43174 | |
| GFSKSNGGNLLCAVD | 166 | O95834 | |
| GNGIKCIDLDECSNG | 1401 | P35556 | |
| QEATTVSCFRGKGEG | 276 | P26927 | |
| GDGTECRDIIAKSQG | 341 | D6RIA3 | |
| SQEARCGGASGGKLA | 211 | Q9NSC2 | |
| CSELKGQLGEAEGEN | 951 | Q9UPN4 | |
| EGKKNTCNGGNSEAV | 416 | P10243 | |
| NSLRVDVQAGACEGK | 556 | P0C0L4 | |
| GQFNGKRCTDAVGDR | 71 | P02748 | |
| KNGNVSKDLSAGCGE | 216 | Q5THK1 | |
| GKNSEFEGGKSTVNC | 141 | Q99567 | |
| GGQRCSAQSRGAKNS | 296 | Q5JRS4 | |
| EDAACGGQGQLSTVL | 561 | Q9Y2M0 | |
| LCDRDGNKSQDSGIA | 31 | Q96FC7 | |
| GGGLRETKETAVQCD | 331 | Q8N1G1 | |
| LGKNGREVNGCSGVN | 441 | Q6P4F7 | |
| KRALTECQGAVGLGS | 151 | Q9NX07 | |
| LSGKDVNGECGNFVR | 106 | Q13275 | |
| TCKDQGLGDNGATQH | 4296 | Q8WXH0 | |
| AVDGAGGKSQVASLC | 396 | Q7LBE3 | |
| ELKEKSQACGGNLGS | 386 | Q9Y6E0 | |
| SQACGGNLGSIEELR | 391 | Q9Y6E0 | |
| AENDRLKSESQGSGC | 1951 | Q8IVL1 | |
| GDSRGVLCDKDGNAI | 211 | Q5SGD2 | |
| EKKRGAAGGNLSSRC | 916 | O75182 | |
| NTQSLSGECRKGVGA | 71 | Q66K80 | |
| KGERQQQGEAHDGAC | 756 | Q6IE81 | |
| RLEGSDKLTCQGNSQ | 471 | Q4LDE5 | |
| EDGTAVASVGKGQRC | 541 | Q5JTZ9 | |
| QDSGAGETAKAARCQ | 116 | Q0VD83 | |
| KSKAGSGACQDRSGQ | 141 | Q0VD83 | |
| LERCSGNIKADTTGG | 631 | Q86WS4 | |
| CSSVECKGIIGNDGR | 546 | O75153 | |
| NFSCNGKNGSSEGRI | 446 | Q96LI5 | |
| DAATGSVGTQGRLCN | 281 | P56706 | |
| GCSDNVGFGEAISKQ | 131 | Q93098 | |
| KEGEGRCEQVALSSG | 26 | Q9BRP9 | |
| TNRTEGGVCKGATVG | 706 | Q6ZTA4 | |
| SEDCSGEGKDQRGQS | 206 | Q96BF3 | |
| IRNQSKASGSGLCEG | 36 | Q9UMS6 | |
| ERDGGQKGCIESSSV | 1646 | Q13129 | |
| RCSGDGLDSDGNQTL | 216 | Q8IVN8 | |
| GASSDNGCEVKNRKS | 296 | Q9UMS5 | |
| SKQEDKCLRCGGDGT | 166 | O95428 | |
| AGAGGAASQEQKLAC | 1381 | Q92766 | |
| DGGKTENCAVLSGAA | 166 | P05452 | |
| ATGERAKEGISINCG | 286 | Q7Z4S6 | |
| NTSGRLCLNNDTKEG | 226 | P30825 | |
| QGGEKALEICGAQRS | 126 | Q9H0U9 | |
| NQICVGVGRSKDADG | 376 | Q6ZMT1 | |
| SGNSSGIVGRCQKDN | 531 | Q9NYB5 | |
| ISDKTSQERDRGGCG | 1316 | O15014 | |
| NICSDSQGLEGLLSG | 201 | Q6ZS81 | |
| SLGTQGRLCNKTSEG | 296 | Q9H1J7 | |
| CRSNVGKGNIDGNVS | 1616 | Q92576 | |
| GKGNIDGNVSCSENL | 1621 | Q92576 | |
| TQSGTKNLRIQCEGG | 86 | O14543 | |
| CRGDQGGESSLSVSK | 266 | O75326 | |
| IRGTGSGGQLQDLDC | 281 | P08240 | |
| QGSELSVKCGAGRDI | 1836 | Q8WWQ8 | |
| GSLGTQGRLCNKTSE | 316 | P41221 | |
| VNKNCGSVRGGDEIF | 191 | Q04864 | |
| NEKNALAVRGDCGDT | 1836 | P02549 | |
| QTCLQGKFGEEIGSD | 2421 | Q86WI1 | |
| SQDDSGRYKCGLGIN | 101 | P01833 | |
| GESGRNAKNCVLLGN | 51 | Q8WW36 | |
| ASGLVGQENAREACG | 36 | Q9Y265 | |
| SDSACLGQQREGGGT | 481 | Q17R98 | |
| KNSDGRECIKGVNTG | 96 | Q8WV37 | |
| KEERGGQAQSAASGA | 166 | Q13105 | |
| KGGGQECGDSRAQLS | 2306 | O43149 | |
| CRSNSLENEEGRGGN | 1086 | Q9Y2L5 | |
| LDNGGTRKRTSAQCG | 246 | Q14CZ0 | |
| LCDGDKAVGAGNQGR | 986 | Q8NAP3 | |
| KLESQAGICLGDSQG | 646 | Q70CQ2 | |
| GGKGKSINCSELNVR | 56 | Q8IYR6 | |
| GSSEACGKGLQTRAV | 821 | Q9C0I4 | |
| RQSAGQKTTCGQGLE | 146 | Q9UD71 | |
| KAGGGRTRTFADCIQ | 1771 | Q12789 | |
| ESNKDCVGGKRGRAQ | 1406 | Q14669 | |
| GNRKGCGEQVLSSVS | 136 | Q6NT04 | |
| DRNGICKGSSGSLNS | 31 | O60603 | |
| AECGKGFSVGSQLQA | 531 | Q02386 | |
| EQGDLKCGGVEQASS | 1226 | Q5VZL5 | |
| DLGKCESDNTTNGCG | 381 | O94782 | |
| NEACGRLSGDKESSG | 251 | Q9Y6Q6 | |
| RKESQLSLGGQSCAG | 361 | Q9BWF2 | |
| NCGRVNSGEQGTLKL | 561 | Q9UKW4 | |
| AVGCDRQLGSNAKED | 201 | P82987 | |
| AGDGSTCRLVRGQSK | 221 | P82987 |